Mechanical ventilation

Global Mechanical Ventilators Industry

Retrieved on: 
Monday, May 20, 2019

Table 35: European Population By Age Group (2013, 2020 & 2040): Percentage Share Breakdown of Age Groups 0-19, 20-39, 40-59, 60-79, and 80+ (includes corresponding Graph/Chart)

Key Points: 
  • Table 35: European Population By Age Group (2013, 2020 & 2040): Percentage Share Breakdown of Age Groups 0-19, 20-39, 40-59, 60-79, and 80+ (includes corresponding Graph/Chart)
    Table 36: European Recent Past, Current & Future Analysis for Mechanical Ventilators by Geographic Region/Country - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    Table 37: European Historic Review for Mechanical Ventilators by Geographic Region/ Country - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    Table 38: European 14-Year Perspective for Mechanical Ventilators by Geographic Region/ Country - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
    Table 39: European Recent Past, Current & Future Analysis for Mechanical Ventilators by Product Segment - Critical Care, Neonatal, and Portable & Transport Ventilators Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    Table 40: European Historic Review for Mechanical Ventilators by Product Segment - Critical Care, Neonatal, and Portable & Transport Ventilators Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2
    Table 41: European 14-Year Perspective for Mechanical Ventilators by Product Segment - Percentage Breakdown of Dollar Sales for Critical Care, Neonatal, and Portable & Transport Ventilators for Years 2011, 2018 and 2
    Table 42: French Recent Past, Current & Future Analysis for Mechanical Ventilators by Product Segment - Critical Care, Neonatal, and Portable & Transport Ventilators Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    Table 43: French Historic Review for Mechanical Ventilators by Product Segment - Critical Care, Neonatal, and Portable & Transport Ventilators Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2
    Table 44: French 14-Year Perspective for Mechanical Ventilators by Product Segment - Percentage Breakdown of Dollar Sales for Critical Care, Neonatal, and Portable & Transport Ventilators for Years 2011, 2018 and 2
    Table 45: German Recent Past, Current & Future Analysis for Mechanical Ventilators by Product Segment - Critical Care, Neonatal, and Portable & Transport Ventilators Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    Table 46: German Historic Review for Mechanical Ventilators by Product Segment - Critical Care, Neonatal, and Portable & Transport Ventilators Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2
    Table 47: German 14-Year Perspective for Mechanical Ventilators by Product Segment - Percentage Breakdown of Dollar Sales for Critical Care, Neonatal, and Portable & Transport Ventilators for Years 2011, 2018 and 2
    Table 48: Italian Recent Past, Current & Future Analysis for Mechanical Ventilators by Product Segment - Critical Care, Neonatal, and Portable & Transport Ventilators Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    Table 49: Italian Historic Review for Mechanical Ventilators by Product Segment - Critical Care, Neonatal, and Portable & Transport Ventilators Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2
    Table 50: Italian 14-Year Perspective for Mechanical Ventilators by Product Segment - Percentage Breakdown of Dollar Sales for Critical Care, Neonatal, and Portable & Transport Ventilators for Years 2011, 2018 and 2
    Table 51: The UK Recent Past, Current & Future Analysis for Mechanical Ventilators by Product Segment - Critical Care, Neonatal, and Portable & Transport Ventilators Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    Table 52: The UK Historic Review for Mechanical Ventilators by Product Segment - Critical Care, Neonatal, and Portable & Transport Ventilators Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2
    Table 53: The UK 14-Year Perspective for Mechanical Ventilators by Product Segment - Percentage Breakdown of Dollar Sales for Critical Care, Neonatal, and Portable & Transport Ventilators for Years 2011, 2018 and 2
    Table 54: Spanish Recent Past, Current & Future Analysis for Mechanical Ventilators by Product Segment - Critical Care, Neonatal, and Portable & Transport Ventilators Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    Table 55: Spanish Historic Review for Mechanical Ventilators by Product Segment - Critical Care, Neonatal, and Portable & Transport Ventilators Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2
    Table 56: Spanish 14-Year Perspective for Mechanical Ventilators by Product Segment - Percentage Breakdown of Dollar Sales for Critical Care, Neonatal, and Portable & Transport Ventilators for Years 2011, 2018 and 2
    Table 57: Russian Recent Past, Current & Future Analysis for Mechanical Ventilators by Product Segment - Critical Care, Neonatal, and Portable & Transport Ventilators Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    Table 58: Russian Historic Review for Mechanical Ventilators by Product Segment - Critical Care, Neonatal, and Portable & Transport Ventilators Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2
    Table 59: Russian 14-Year Perspective for Mechanical Ventilators by Product Segment - Percentage Breakdown of Dollar Sales for Critical Care, Neonatal, and Portable & Transport Ventilators for Years 2011, 2018 and 2

New Phase 2b Analysis Suggests AEROSURF® may Reduce Incidence and Severity of Bronchopulmonary Dysplasia in Preterm Infants with RDS

Retrieved on: 
Friday, May 10, 2019

This exploratory result is encouraging and merits further study as we continue to advance the clinical development of AEROSURF.

Key Points: 
  • This exploratory result is encouraging and merits further study as we continue to advance the clinical development of AEROSURF.
  • Bronchopulmonary dysplasia (BPD), a chronic lung disease of the newborn, is one of the most common complications of prematurity and treatments for RDS.
  • The AEROSURF phase 2 clinical program in premature infants consisted of three multicenter, randomized, controlled clinical trials in a total of 341 premature infants receiving nasal continuous positive airway pressure (nCPAP) for RDS.
  • AEROSURF is being developed to potentially reduce or eliminate the need for endotracheal intubation and mechanical ventilation in the treatment of premature infants with respiratory distress syndrome (RDS).

N8 Medical Announces First-in-Human Use of its CeraShield™ Endotracheal Tube

Retrieved on: 
Thursday, April 25, 2019

DUBLIN, Ohio, April 25, 2019 /PRNewswire/ --N8 Medical, LLC (N8 Medical) today announced its first-in-human clinical trials of its flagship CeraShield endotracheal tube (CeraShield ETT) for intensive care unit patients expected to require mechanical ventilation for more than 48 hours.N8 Medical is encouraged by preliminary study data and believes that the CeraShield ETT will demonstrate safety and a significant reduction in bacterial and fungal fouling of the tube.

Key Points: 
  • DUBLIN, Ohio, April 25, 2019 /PRNewswire/ --N8 Medical, LLC (N8 Medical) today announced its first-in-human clinical trials of its flagship CeraShield endotracheal tube (CeraShield ETT) for intensive care unit patients expected to require mechanical ventilation for more than 48 hours.N8 Medical is encouraged by preliminary study data and believes that the CeraShield ETT will demonstrate safety and a significant reduction in bacterial and fungal fouling of the tube.
  • Ronald Bracken, Chief Operating Officer of N8 Medical, stated, "We are pleased with these developments regarding the initial clinical usage of the CeraShield technology.
  • CAUTION: In Canada, the CeraShield Endotracheal Tube obtained Health Canada Investigational Testing Authorization and remains the subject of investigational testing regarding the safety of the CeraShield ETT.
  • In the United States, the CeraShield Endotracheal Tube has not been granted marketing approval by FDA and is not yet available for commercial sale.

FDA Cleared MediPines Gas Exchange Monitor Measures Freedivers' Lung Efficiency in Ground-Breaking Study

Retrieved on: 
Friday, April 12, 2019

The recently FDA 510(k) cleared, MediPines Gas Exchange Monitor is a breakthrough, portable respiratory monitoring device invented to provide real-time, clinically actionable data.

Key Points: 
  • The recently FDA 510(k) cleared, MediPines Gas Exchange Monitor is a breakthrough, portable respiratory monitoring device invented to provide real-time, clinically actionable data.
  • It has been challenging, in the past, to assess the consequences of deep dives on pulmonary gas exchange, especially during true field-based conditions.
  • "Measuring oxygen deficit has allowed us to establish the impact of 'lung squeeze' on gas exchange inefficiency in elite freedivers," stated Dr. Philip Ainslie.
  • "Understanding gas exchange inefficiency in respiratory patients is fundamental to improving patient outcomes," according to Dr. John B.

Global Critical Care Ventilators Market 2019-2023 | Growing Focus Toward Non-Invasive Ventilation in Critical Care to Boost Growth | Technavio

Retrieved on: 
Friday, April 12, 2019

The global critical care ventilators market is expected to post a CAGR close to 7% during the period 2019-2023, according to the latest market research report by Technavio.

Key Points: 
  • The global critical care ventilators market is expected to post a CAGR close to 7% during the period 2019-2023, according to the latest market research report by Technavio.
  • This global critical care ventilators market 2019-2023 research report also analyzes other important trends and market drivers that will affect market growth over 2019-2023.
  • Global critical care ventilators market: Growing focus toward non-invasive ventilation in critical care
    Non-invasive ventilation is known for providing ventilatory support without using invasive artificial airways such as an endotracheal tube or tracheostomy tube.
  • Global critical care ventilators market: Segmentation analysis
    This market research report segments the global critical care ventilators market by product (mounted ventilators and portable ventilators) and geographical regions (Asia, North America, Europe, and ROW).

Global Mechanical Ventilators Market Forecasts 2019-2026: Dominated by Draeger Medical, GE Healthcare, Koninklijke Philips, Teleflex, and Smiths Medical - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 11, 2019

The global mechanical ventilators market size is expected to reach USD 7.13 billion by 2026 registering a CAGR of 6.6%, according to this report.

Key Points: 
  • The global mechanical ventilators market size is expected to reach USD 7.13 billion by 2026 registering a CAGR of 6.6%, according to this report.
  • Growing geriatric population and technological innovation in respiratory care devices are the major factors driving the market.
  • Moreover, increasing incidence of Chronic Obstructive Pulmonary Disease (COPD) and respiratory emergencies is contributing to the market expansion.
  • According to the estimates by the WHO, currently, approximately 90% of COPD deaths occur in low- and middle-income countries.

In Comparison of Standard Treatment and Sustained Inflations for Extremely Preterm Infants, Standard Treatment Prevails

Retrieved on: 
Tuesday, March 26, 2019

Pooled data from smaller randomized trials were conflicting: one showed that sustained inflations reduced the need for mechanical ventilation.

Key Points: 
  • Pooled data from smaller randomized trials were conflicting: one showed that sustained inflations reduced the need for mechanical ventilation.
  • In infants younger than 30 weeks gestational age, sustained inflations are commonly used in delivery rooms in Europe, but not in the United States.
  • This was possible using sustained inflations at delivery, as these appeared beneficial in animal models, and in smaller prior human studies.
  • Effect of Sustained Inflations vs Intermittent Positive Pressure Ventilation on Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants: The SAIL Randomized Clinical Trial.

Emergency Department Subgroup Study Showed Hi-VNI® Technology Had Similar Outcomes to Non-invasive Positive Pressure Ventilation in Management of Respiratory Distress Among Acute Decompensated Heart Failure Patients

Retrieved on: 
Tuesday, March 26, 2019

This analysis shows that even if that diagnosis is respiratory distress due to exacerbation of CHF, Hi-VNI Technology provides Mask-Free NIV for spontaneously breathing patients and is potentially a viable alternative to NiPPV.

Key Points: 
  • This analysis shows that even if that diagnosis is respiratory distress due to exacerbation of CHF, Hi-VNI Technology provides Mask-Free NIV for spontaneously breathing patients and is potentially a viable alternative to NiPPV.
  • This is particularly important for ED clinicians who may need to make treatment decisions before knowing the patient diagnosis.
  • Vapotherm, Inc.(NYSE: VAPO) is a publicly traded developer and manufacturer of advanced respiratory technology based in Exeter, New Hampshire, USA.
  • Hi-VNI Technologyis mask-free noninvasive ventilation for spontaneously breathing patients and a front-line tool for relieving respiratory distressincluding hypercapnia, hypoxemia, and dyspnea.

The critical care ventilators market will register a CAGR of almost 7% by 2023

Retrieved on: 
Thursday, February 28, 2019

COPD is one of the major chronic respiratory problems, for which patient may need to get admitted in a critical care setting and would require critical care ventilators.

Key Points: 
  • COPD is one of the major chronic respiratory problems, for which patient may need to get admitted in a critical care setting and would require critical care ventilators.
  • A cancer patient who require critical care treatment may get admitted in a critical care unit and may require respiratory support, for which critical care ventilators are required.
  • Technavio's analysts have predicted that the critical care ventilators market will register a CAGR of almost 7% by 2023.
  • Companies are focusing on developing advanced critical care ventilators, which can increase their sales, improve their market share, and induce market competitiveness.

Global Critical Care Ventilators Market 2019-2023 with Drgerwerk AG & Co, Getinge, Hamilton Medical, Koninklijke Philips, Medtronic & VYAIRE - ResearchAndMarkets.com

Retrieved on: 
Thursday, February 28, 2019

COPD is one of the major chronic respiratory problems, for which patient may need to get admitted in a critical care setting and would require critical care ventilators.

Key Points: 
  • COPD is one of the major chronic respiratory problems, for which patient may need to get admitted in a critical care setting and would require critical care ventilators.
  • A cancer patient who require critical care treatment may get admitted in a critical care unit and may require respiratory support, for which critical care ventilators are required.
  • Companies are focusing on developing advanced critical care ventilators, which can increase their sales, improve their market share, and induce market competitiveness.
  • Key players in the global critical care ventilators market are Drgerwerk AG & Co. KGaA, Getinge AB, Hamilton Medical, Koninklijke Philips N.V., Medtronic, VYAIRE.